MAPK7 and cancer: The cytotoxic activity of ERK5-IN-1 were evaluated in vitro using a panel of cancer cell lines stabling expressing ABCB1 or ABCG2 and ERK5-IN-1 at non-toxic concentrations up to 0.4 μM were used for reversal assay in vitro (Fig. 1).